Philips AI Gains FDA Clearance for Heart Valve Guidance
AMSTERDAM, Netherlands, March 26, 2026 Royal Philips announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...
AI in Healthcare
Advertisement
GE Leads EU AI Cardio-Oncology Care Consortium
Chicago, USA – March 26, 2026 GE HealthCare announced a leading industrial role in the €50.5 million COMPASS consortium,...
Tempus, Daiichi Sankyo Advance AI in ADC Oncology Trials
CHICAGO, Illinois, March 25, 2026 Tempus AI has announced a strategic collaboration with Daiichi Sankyo to accelerate AI-driven biomarker...
Tempus Study Shows Genomic Profiling Expands Cancer Care
CHICAGO — March 11, 2026 Tempus AI, Inc., a technology company focused on advancing precision medicine through artificial intelligence...
SHERPA Launches AI Trials for Brain and Cancer Care
AMSTERDAM, the Netherlands, March 3, 2026 The SHERPA research consortium, coordinated by Royal Philips, has initiated seven clinical studies...
Advertisements
AI-NGS Test Detects AML, MDS Relapse Post-Transplant
BRISBANE, Calif., Feb. 12, 2026 — CareDx announced pivotal clinical validation results for AlloHeme, the first AI-powered, next-generation sequencing...
BrightInsight Raises $13M to Scale AI Medication Adherence Tech
SAN JOSE, Calif., January 20, 2026 — BrightInsight announced a $13 million strategic investment to accelerate development of its...
FDA Grants Ceribell Breakthrough Status for LVO Stroke EEG
SUNNYVALE, Calif. | January 5, 2026 — Ceribell has received FDA Breakthrough Device Designation for its Large Vessel Occlusion...
Global Immunoassays Market to Reach USD 42.77 Billion by 2034 Driven by Advanced Diagnostics and Precision Medicine
OTTAWA, November 5, 2025 — A new market report from Nova One Advisor, a subsidiary of Precedence Research, projects...
Verily and UCHealth Launch AI Collaboration to Revolutionize Clinical Research
October 14, 2025 | Dallas, TX & Aurora, CO — Verily, UCHealth, the University of Colorado Anschutz, and RefinedScience...
Advertisement
